Boost to COVID-19 vaccine and therapy research
COVID-19 vaccine and therapy research has been boosted by six new projects in rapid response. The six new studies into the novel coronavirus have...
Positive topline results for AbbVie’s venetoclax/azacitidine combination in AML
AbbVie has announced the VIALE-A (M15-656) trial of VENCLEXTA® (venetoclax) in combination with azacitidine versus azacitidine in combination with placebo met its dual primary...
Celltrion Group completes first step in developing antiviral treatment to fight COVID-19
Celltrion Group today announced key milestones in its efforts to fight the 2019 novel coronavirus (COVID-19) pandemic. As part of its emergency preparedness plan...
eyeforpharma Barcelona goes VIRTUAL
Spotlight: Advertorial from Pf Partners
Hi Covid-19 has undoubtedly created one of the most challenging environments of the modern era. Together, we must step up to...
CMA launches COVID-19 taskforce to monitor market practices
The CMA is launching a COVID-19 taskforce to tackle negative impacts within its remit of the coronavirus pandemic. The outbreak of Covid-19 is an unprecedented...
LifeArc launches £10m COVID-19 clinical research fund
LifeArc, a UK-based medical research charity, has created a £10m COVID-19 clinical research fund to support research to accelerate the development and testing of...
Synairgen to start trial of SNG001 in COVID-19
Respiratory drug discovery and development company Synairgen has received expedited approvals from the Medicines and Healthcare products Regulatory Agency (MHRA) and Health Research Authority...
Study of siltuximab for treating COVID-19 serious respiratory complications initiated
A study of siltuximab for treating COVID-19 serious respiratory complications has been initiated. EUSA Pharma has announced the initiation of the Papa Giovanni XXIII Hospital...
First coronavirus vaccine clinical trial starts
The first coronavirus vaccine clinical trial has started at Kaiser Permanente Washington Health Research Institute (KPWHRI) in Seattle. The Phase 1 clinical trial is...
FDA emergency authorisation for Roche’s COVID-19 test
Roche has announced that the U.S. Food and Drug Administration (FDA) has issued an Emergency Use Authorization (EUA) for its COVID-19 test, the cobas®...
Latest articles
Reputation control: changing perceptions of pharma
Amanda Barrel investigates pharma’s reputation, self-regulation, compliance and how pharma can change perceptions of the work it does. Top 5 Takeaways
1 Only 57% of people...
Medicines and Medical Devices Bill: Getting it right for all
With the Medicines and Medical Devices Bill heading through Parliament, Claudia Rubin asks what is required to get this legislation right? The Government would like...
Popular articles
NICE guidelines on active management of patients with COVID-19
The National Institute for Health and Care Excellence (NICE) has published its first three rapid guidelines on the active management of patients with COVID-19...
FDA emergency authorisation for Roche’s COVID-19 test
Roche has announced that the U.S. Food and Drug Administration (FDA) has issued an Emergency Use Authorization (EUA) for its COVID-19 test, the cobas®...
UPDATED: MHRA guidance on coronavirus (COVID-19)
The MHRA is producing guidance on coronavirus (COVID-19) for industry. The Medicines and Healthcare products Regulatory Agency (MHRA) is working closely with Department of Health...
Looking for a breakthrough in Parkinson’s research
Will recent investments and developments offer hope for people living with Parkinson’s? Pf explores the condition and work happening to find a breakthrough in...
Does NICE hold the cards to drug pricing and reimbursement?
The upcoming NICE Methods Review begs the question: at what price does a drug represent value for money to the NHS? Rebecca Lanning discusses...